Recent advancements in the understanding of gastric cancer have led to the development of new treatments and diagnostic tools. Research is ongoing into the genetic and molecular mechanisms of gastric cancer, which may lead to more effective targeted therapies. Clinical trials are investigating the efficacy of combination therapies, including immunotherapy and targeted drugs. Additionally, advancements in liquid biopsy techniques offer the potential for earlier detection and monitoring of treatment response.
